The B-RafV600E inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury
2014 · Cell Death and Disease · 229 citations
https://doi.org/10.1038/cddis.2014.241
Y
Yu Chen
Jimei University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
79
Papers
1.5K
Citations
23
h-index
34
i10-index
Yu Chen is an academic researcher from Jimei University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & MicroRNA in disease regulation & Cancer-related molecular mechanisms research. The author has an h-index of 23, co-authored 68 publications.
ORCID: 0000-0001-6126-0082Papers by this author
worksWogonin attenuates liver fibrosis via regulating hepatic stellate cell activation and apoptosis
2019 · International Immunopharmacology · 63 citations
https://doi.org/10.1016/j.intimp.2019.05.056
Rosmarinic acid reduces the resistance of gastric carcinoma cells to 5-fluorouracil by downregulating FOXO4-targeting miR-6785-5p
2018 · Biomedicine & Pharmacotherapy · 51 citations
https://doi.org/10.1016/j.biopha.2018.10.061
Altered patterns of association between cortical thickness and subcortical volume in patients with first episode major depressive disorder: A structural MRI study
2016 · Psychiatry Research Neuroimaging · 38 citations
https://doi.org/10.1016/j.pscychresns.2016.12.001
Homeoprotein SIX1 compromises antitumor immunity through TGF-β-mediated regulation of collagens
2021 · Cellular and Molecular Immunology · 23 citations
https://doi.org/10.1038/s41423-021-00800-x
N6-Methyladenosine modification of circDcbld2 in Kupffer cells promotes hepatic fibrosis via targeting miR-144-3p/Et-1 axis
2024 · Acta Pharmaceutica Sinica B · 6 citations
https://doi.org/10.1016/j.apsb.2024.11.003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat